Mahsulot tavsifi
Belviq® (lorcaserin hydrochloride) was approved by FDA in June 2012 for chronic weight management. It's for adults with BMI 30+ (obese) or BMI 27+ (overweight) with weight-related conditions
#bmi#obesity#weight management#lorcaserine#belviq
Muallif
ONLY PPT & PPTXTasdiqlangan muallif
- Hujjatlari
- 28 087
- Sotilgan
- 1 750
